ATHA - Hot Stocks: BMY collaboration CAI merger deal GERN pops on clinical trial

solarseven/iStock via Getty Images Next year at this time, the markets might be closed for the new Juneteenth federal holiday. For today, though, trading remain open, with Bristol Myers (BMY), CAI International (CAI), Geron (GERN) and Athira Pharma (ATHA) all making news before Friday's open. Bristol Myers has struck a joint collaboration deal that will involve paying more than $2 billion to Eisai (ESALF). The deal is aimed at an experimental cancer therapy, MORAb-202, an antibody-drug conjugate. CAI International jumped more than 45% in Friday's pre-market after the company agreed to be acquired by Mitsubishi HC Capital (MIUFY). The company has also promoted Timothy Page to the position of CEO. Geron also saw a significant advance before the opening bell. Shares rallied about 16% on the publication of strong data for its ongoing IMbark trial. Athira Pharma moved in the opposite direction in the pre-market action after the company revealed that

For further details see:

Hot Stocks: BMY collaboration, CAI merger deal, GERN pops on clinical trial